GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

IMDX · Mar 31, 2026

Insight Molecular Diagnostics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001642380-26-000008General Corporate
Capex intensity100thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1915.63% · OPTIONAL · VALID

Operating cash generation0thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-23871.88% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.revenue

-98.50% · CORE · VALID

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

1193.75% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross margin46thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.gross_margin

46.88% · CORE · VALID

Operating margin0thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.operating_margin

-13790.63% · CORE · VALID

R&D intensity100thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

15478.13% · OPTIONAL · VALID

SBC intensity100thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1921.88% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Period transition

What moved in the state?

Capex Intensity Increased
Previous
78.55%
Current
1915.63%
Delta
1837.08%
Cash Generation Decreased
Previous
-547.08%
Current
-23871.88%
Delta
-23324.80%
Growth Decreased
Previous
115.58%
Current
-98.50%
Delta
-214.08%
Inventory Pressure Increased
Previous
11.00%
Current
1193.75%
Delta
1182.75%
Margin Decreased
Previous
56.67%
Current
46.88%
Delta
-9.80%
Profitability Decreased
Previous
-1260.76%
Current
-13790.63%
Delta
-12529.86%
R And D Intensity Increased
Previous
392.11%
Current
15478.13%
Delta
15086.02%
Sbc Intensity Increased
Previous
54.72%
Current
1921.88%
Delta
1867.15%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.